Disc Medicine, Inc.
IRON
Rang in aandelen
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aandeelprijs
$75.39
Laatst gesynchroniseerd: 2026-10-22
Marktkapitalisatie
$2.89B
Verandering (1 dag)
-0.80%
Verandering (1 jaar)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Categorie
Healthcare
Koersgeschiedenis voor Disc Medicine, Inc. (IRON)
Hoogste slotkoers: $64.58 op 2026-10-01
Laagste slotkoers: $104.87 op 2020-08-01
Laagste slotkoers: $104.87 op 2020-08-01
Koersgeschiedenis van Disc Medicine, Inc. van 2020 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -15.22% |
| 2025 | 35.37% |
| 2024 | 10.81% |
| 2023 | 264.05% |
| 2022 | -41.22% |
| 2021 | -73.71% |
| 2020 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $536.13 | 26.86% |
US
|
|
| $200.12 | 662.34% |
US
|
|
| $137.26 | -3.15% |
AU
|
|
| $291.76 | 1.91% |
BE
|
|
| $880.01 | 8.35% |
NL
|
